Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 26, 2024

BUY
$3.45 - $4.66 $44,705 - $60,384
12,958 New
12,958 $57,000
Q1 2023

May 01, 2023

SELL
$2.89 - $4.1 $494 - $701
-171 Reduced 0.97%
17,380 $67,000
Q4 2022

Feb 15, 2023

BUY
$2.02 - $3.25 $709 - $1,140
351 Added 2.04%
17,551 $49,000
Q3 2022

Nov 07, 2022

SELL
$2.04 - $3.03 $17,158 - $25,485
-8,411 Reduced 32.84%
17,200 $36,000
Q2 2022

Aug 09, 2022

BUY
$2.55 - $4.38 $65,308 - $112,176
25,611 New
25,611 $67,000

Others Institutions Holding ETON

About Eton Pharmaceuticals, Inc.


  • Ticker ETON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,297,000
  • Market Cap $450M
  • Description
  • Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...
More about ETON
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.